clopenthixol has been researched along with Aura in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hertrich, O | 1 |
| Izmeth, MG; Khan, SY; Kumarajeewa, DI; Shivanathan, S; Veall, RM; Wiley, YV | 1 |
| Diehl, LW | 1 |
1 trial(s) available for clopenthixol and Aura
| Article | Year |
|---|---|
Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Clopenthixol; Epilepsy; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Thioxanthenes | 1988 |
2 other study(ies) available for clopenthixol and Aura
| Article | Year |
|---|---|
[Ataractic treatment in psychiatry and general medicine. Overview of preparations, 3].
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Chlorprothixene; Clobazam; Clomipramine; Clonazepam; Clopenthixol; Epilepsy; Humans; Schizophrenia; Tranquilizing Agents | 1983 |
[Severe adverse effects of ciatyl in antiepileptic long-term therapy].
Topics: Adult; Clopenthixol; Drug Eruptions; Epilepsy; Female; Humans; Leukopenia; Middle Aged; Mouth Diseases; Piperazines; Salivation; Time Factors; Tranquilizing Agents; Xanthenes | 1972 |